Amir Garakani

  • ASSISTANT PROFESSOR Psychiatry
Print ProfilePrint Profile

Specialty

Certifications

  • Forensic Psychiatry

  • Psychiatry, American Board of Psychiatry and Neurology

Education

  • MD, SUNY Upstate Medical Center

  • Residency, Psychiatry
    Mount Sinai School of Medicine

  • Fellowship, Forensic Psych
    New York University Medical Center

Publications

Garakani A, Martinez JM, Yehuda R, Gorman JM. Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment. J Affect Disord;.

Saraiya A, Garakani A, Billick SB. Mental Health Approaches to Child Victims of Acts of Terrorism. Psychiatr Q 2012 Jun;.

Goldberg JF, Garakani A, Ackerman SH. Clinician- versus self-rated screening for bipolar disorder among inpatients with mood symptoms and substance abuse. J Clin Psychiatry 2012; 73(12): 1525–1530.

Martinez JM, Garakani A, Yehuda R, Gorman JM. Proinflammatory and “resiliency” proteins in the CSF of patients with major depression. Depress Anxiety 2012; 29(1): 32-38.

Garakani A. Urinary retention with a high dose of escitalopram. Gen Hosp Psychiatry 2010; 32(6): e11-e12.

Hirschowitz J, Kolevzon A, Garakani A. The pharmacological treatment of bipolar disorder: the question of modern advances. Harv Rev Psychiatry 2010; 18(5): 266-278.

Krystal JH, Mathew SJ, D’Souza DC, Garakani A, Gunduz-Bruce H, Charney DS. Potential psychiatric applications of metabotropic glutamate receptor glutamate receptor agonists and antagonists. CNS Drugs 2010; 24(8): 669-693.

Martinez JM, Garakani A, Kaufmann H, Aaronson CJ, Gorman JM. Heart rate and blood pressure changes during autonomic nervous system challenge in panic disorder patients (impact of severity of illness). Psychosom Med 2010; 72(5): 442-449.

Billick SB, Perez DL, Garakani A. A clinical study of competency to consent to hospitalization and treatment in geriatric inpatients. J Forensic Sci 2009; 54(4): 943-946.

Mathew SJ, Garakani A, Reinhard JF, Oshana S, Donahue S. Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: A 28-day, open-label study. Clin Ther 2008; 30(9): 1658-1666.

Garakani A, Martinez JM, Aaronson CJ, Voustianiouk A, Kaufmann H, Gorman JM. Effect of medication and psychotherapy on heart rate variability in panic disorder. Depress Anxiety 2009; 26(3): 251-258.

Garakani A, Martinez JM, Marcus S, Weaver J, Rickels K, Fava M, Hirschowitz J. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder. Int Clin Psychopharmacol 2008; 23(5): 269-275.

Garakani A, Buchsbaum MS, Newmark RE, Goodman C, Aaronson CJ, Martinez JM, Torosjan Y, Chu K, Gorman JM. The effect of doxapram on brain imaging in patients with panic disorder. Eur Neuropsychopharmacol 2007; 17(10): 672-686.

Garakani A, Mathew SJ, Charney DS. Neurobiology of anxiety disorders and implications for treatments. Mt Sinai J Med 2006; 73(7): 941-949.

Garakani A, Hirschowitz J, Katz CL. General disaster psychiatry. Psychiatr Clin North Am 2004; 27: 391-406.

Quitkin FM, Garakani A, Kelly KE. Electrolyte-balanced sports drink for polydipsia-hyponatremia in schizophrenia. Am J Psychiatry 2003; 160: 385-386.

Garakani A, Win T, Virk S, Gupta S, Kaplan DS, Masand PS. Comorbidity of irritable bowel syndrome in psychiatric patients: A review. Am J Ther 2003; 10: 61-67.

Marshall RD, Garakani A. Psychobiology of the acute stress response and its relationship to the psychobiology of PTSD. Psychiatr Clin North Am 2002; 25: 385-395.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Garakani did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

17 East 102 Street
New York, NY 10029

Tel: 212-659-8828

Address

128 East Avenue
Norwalk, CT 06851

Tel: 203-858-8460